Articles by Disease (Kaposi's Sarcoma)

Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents

Journal: Current Medicinal Chemistry
Volume: 23
Page: 455-463
Author(s): Hamed Mirzaei, Amirhossein Sahebkar, Amir Avan, Mahmoud R. Jaafari, Rasoul Salehi, Hossein Salehi, Hossein Baharvand, Abbas Rezaei, Jamshid Hadjati, John M. Pawelek and Hamid R. Mirzaei

Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique

Journal: Current Pharmaceutical Design
Volume: 22
Page: 870-878
Author(s): Xenia A. Glukhova, Olga V. Prusakova, Julia A. Trizna, Michael M. Zaripov, Gaida V. Afanas’eva, Anatoly S. Glukhov, Rimma A. Poltavtseva, Alexei A. Ivanov, Marco Avila-Rodriguez, George E. Barreto, Gjumrakch Aliev and Igor P. Beletsky

Molecular Approach to Targeted Therapy for Multiple Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15
Page: 20-34
Author(s): Gajanan V. Sherbet

Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors

Journal: Current Drug Metabolism
Volume: 17
Page: 118-128
Author(s): Lisi Qi, Yuanyuan Guo, Pei Zhang, Xiaorong Cao and Yuxia Luan

Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery

Journal: Current Biotechnology
Volume: 4
Page: 319-344
Author(s): Meerza Abdul Razak, Shankarappa Devi Prasad Boggupalli and Buddolla Viswanath

Therapy Stratifications and Novel Approach in Pursuit of Aids Related Kaposi’s Sarcoma Management- A paradigm for Non Invasiveness

Journal: Current Drug Delivery
Volume: 12
Page: 770-781
Author(s): Meenu Sharma, Vijay Sharma and Kamla Pathak

Articles by Disease (Kaposi's Sarcoma)

Application of Mesenchymal Stem Cells in Melanoma: A Potential Therapeutic Strategy for Delivery of Targeted Agents

Updates on the Production of Therapeutic Antibodies Using Human Hybridoma Technique

Molecular Approach to Targeted Therapy for Multiple Sclerosis

Preventive and Therapeutic Effects of the Retinoid X Receptor Agonist Bexarotene on Tumors

Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery

Therapy Stratifications and Novel Approach in Pursuit of Aids Related Kaposi’s Sarcoma Management- A paradigm for Non Invasiveness

HIV-1 TAT and IMMUNE DYSREGULATION in AIDS PATHOGENESIS: a THERAPEUTIC TARGET

Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?

The CCL2/CCR2 Axis in the Pathogenesis of HIV-1 Infection: A New Cellular Target for Therapy?

The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity